S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction

被引:61
作者
Herrera-Mundo, Maria N.
Silva-Adaya, Daniela
Maldonado, Perla D.
Galvan-Arzate, Sonia
Andres-Martinez, Leticia
Perez-De La Cruz, Veronica
Pedraza-Chaverri, Jose
Santamaria, Abel [1 ]
机构
[1] Inst Nacl Neurol & Neurocirug, Lab Aminoacidos Excitadores, Mexico City 14269, DF, Mexico
[2] Inst Nacl Neurol & Neurocirug, Lab Patol Vasc Cerebral, Mexico City 14269, DF, Mexico
[3] Inst Nacl Neurol & Neurocirug, Dept Neuroquim, Mexico City 14269, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico
关键词
3-nitropropionic acid; S-allylcysteine; garlic-derived compounds; superoxide dismutase; hyperactivity; mitochondrial reducing activity; antioxidant defense;
D O I
10.1016/j.neures.2006.04.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated the effects of S-allylcysteine (SAC) on early behavioral alterations, striatal. changes in superoxide dismutase (SOD) activity, lipid peroxidation (LP) and mitochondrial dysfunction induced by the systemic infusion of 3-nitropropionic acid (3-NPA) to rats. SAC (300 mg/kg, i.p.), given to animals 30 min before 3-NPA (30 mg/kg, i.p.), prevented the hyperkinetic pattern evoked by the toxin. In addition, 3-NPA alone produced decreased activities of manganese- (Mn-SOD) and copper/zinc-dependent superoxide dismutase (Cu,Zn-SOD), increased LP (evaluated as the formation of lipid fluorescent products) and produced mitochondrial dysfunction in the striatum (measured as decreased 3-(3,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction). In contrast, pretreatment of 3-NPA-injected rats with SAC resulted in a significant prevention of all these markers. Our findings suggest that the protective actions of SAC are related with its antioxidant properties, which in turn may be accounting for the preservation of SOD activity and primary mitochondrial tasks. (c) 2006 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 39 条
[1]  
Alexandrov SY, 2003, J HIGH ENERGY PHYS
[2]  
BEAL MF, 1993, J NEUROSCI, V13, P4181
[3]   CHARACTERIZATION OF THE CELLULAR REDUCTION OF 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE (MTT) - SUBCELLULAR-LOCALIZATION, SUBSTRATE DEPENDENCE, AND INVOLVEMENT OF MITOCHONDRIAL ELECTRON-TRANSPORT IN MTT REDUCTION [J].
BERRIDGE, MV ;
TAN, AS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (02) :474-482
[4]   Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration [J].
Binienda, Z ;
Kim, CS .
NEUROSCIENCE LETTERS, 1997, 230 (03) :199-201
[5]   Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain [J].
Binienda, Z ;
Simmons, C ;
Hussain, S ;
Slikker, W ;
Ali, SF .
NEUROSCIENCE LETTERS, 1998, 251 (03) :173-176
[6]  
Bizat N, 2003, J NEUROSCI, V23, P5020
[7]   Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: A speculative explanation [J].
Borlongan, CV ;
Nishino, H ;
Sanberg, PR .
NEUROSCIENCE RESEARCH, 1997, 28 (03) :185-189
[8]   3-nitropropionic acid animal model and Huntington's disease [J].
Borlongan, CV ;
Koutouzis, TK ;
Sanberg, PR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (03) :289-293
[9]   Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model [J].
Borlongan, CV ;
Koutouzis, TK ;
Freeman, TB ;
Hauser, RA ;
Cahill, DW ;
Sanberg, PR .
BRAIN RESEARCH PROTOCOLS, 1997, 1 (03) :253-257
[10]  
Fontaine M A, 2000, J Neurochem, V75, P1709, DOI 10.1046/j.1471-4159.2000.0751709.x